FindTrial
Sign In

Rezum System

DEVICE4 trials

Sponsors

Boston Scientific Corporation, Chinese University of Hong Kong

Conditions

Adenoma, ProstaticBenign Prostatic HyperplasiaLower Urinary Tract SymptomProstatic AdenomaProstatic HyperplasiaProstatic Hyperplasia, BenignProstatic HypertrophyProstatic Hypertrophy, Benign

Unknown Phase

Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)
CompletedNCT01912339
Boston Scientific CorporationBenign Prostatic Hyperplasia, Lower Urinary Tract Symptom
Start: 2013-07-31End: 2016-10-17Updated: 2020-04-13
Rezum FIM Optimization Study
CompletedNCT02940392
Boston Scientific CorporationAdenoma, Prostatic, Benign Prostatic Hyperplasia, Prostatic Adenoma +4
Start: 2012-03-19End: 2017-05-19Updated: 2021-03-05
Rezum I Pilot Study for Benign Prostatic Hyperplasia
CompletedNCT02943070
Boston Scientific CorporationAdenoma, Prostatic, Benign Prostatic Hyperplasia, Prostatic Adenoma +5
Start: 2012-03-31End: 2018-12-31Updated: 2021-03-16
The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement
TerminatedNCT04340934
Chinese University of Hong KongBenign Prostatic Hyperplasia
Start: 2020-05-13End: 2021-01-29Updated: 2021-06-04

Related Papers

Five-Year Outcomes of Water Vapor Therapy vs Doxazosin, Finasteride, and Combination Therapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Cohort Data From the Medical Therapy of Prostatic Symptoms Trial.
2025-07-17
Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison.
2021-01-306 citations
MP45-12 CONVECTIVE WATER VAPOR ENERGY THERAPY (WAVE) VERSUS PROSTATIC URETHRAL LIFT (PUL) FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH): AN INDIRECT COMPARISON ANCHORED ON SHAM CONTROL.
The Journal of Urology2019-04-01